Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ANN ARBOR, MI--(Marketwired - Oct 29, 2015) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced...
-
ANN ARBOR, MI--(Marketwired - Oct 14, 2015) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today...
-
ANN ARBOR, MI--(Marketwired - Jun 15, 2015) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today provided an...
-
ANN ARBOR, MI--(Marketwired - Mar 12, 2015) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced...
-
ANN ARBOR, MI--(Marketwired - Dec 3, 2014) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced...
-
ANN ARBOR, MI--(Marketwired - Nov 12, 2014) - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced...